Lingyi Fu

Stress–glucocorticoid–TSC22D3 axis compromises therapy-induced antitumor immunity

Heng Yang, Lin Xia, Jian Chen et al. · Nature Medicine · 2019 · 343 citations

Cancer Immunosurveillance, Immune Regulation, Immunology +6

EXPRESSION OF CONCERN: Simultaneous modulation of COX‐2, p300, Akt, and Apaf‐1 signaling by melatonin to inhibit proliferation and induce apoptosis in breast cancer cells

Jingshu Wang, Xiangsheng Xiao, Yun Zhang et al. · Journal of Pineal Research · 2012 · 182 citations

Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response

Jingjing He, Xinxin Xiong, Han Yang et al. · Cell Research · 2022 · 162 citations · Full text

Immunotherapy Response, Tumor Immunology, Cancer Immunosurveillance +15

Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth

Lingyi Fu, Wangbing Chen, Wei Guo et al. · PLoS ONE · 2013 · 107 citations · Full text

Chemoprevention Strategy, Pathology, Cell Death +18

Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells

Jian-Jun Lu, Lingyi Fu, Zhipeng Tang et al. · Oncotarget · 2015 · 106 citations · Full text